Clinical trial
A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors
NCT06208124
Study timeline
Study start (actual)2024-02-27Date precision: day
Registry last updated2025-05-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Advanced Solid Tumor (Phase 1)unresolved
Pancreas Adenocarcinomaunresolved
Non-small Cell Lung Cancerunresolved
Malignant Melanoma (Cutaneous)unresolved
Interventions
IMM-6-415DRUG
Sponsors & collaborators
Immuneering Corporationlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06208124 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.